🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to share our manuscript on how reversal of lactate and PD-1-mediated macrophage immunosuppression can be leveraged to effectively treat PTEN/p53-deficient aggressive-variant prostate cancer: biorxiv.org/content/10.110…

Lovely to see old friends and colleagues & present our work on innate immune activation in prostate cancer at my favorite Coffey-Holden #PCFAcademy brainstorm meeting! Thanks to PCF Science and organizing committee for a fantastic meeting that will move the field forward!

Thrilled to share our paper demonstrating an immunometabolic therapeutic strategy that results in complete and durable tumor control in PTEN/p53-deficient aggressive-variant prostate cancers! Clinical Cancer Research Prostate Cancer Foundation PCF Science University of Chicago Hematology/Oncology UChicago Medicine doi.org/10.1158/1078-0…

Thrilled to share our paper demonstrating an immunometabolic therapeutic strategy that results in complete/durable tumor control in PTEN/p53-deficient aggressive-variant prostate cancers! kiranj chaudagar Clinical Cancer Research Prostate Cancer Foundation @PCF_Science@UChicagoHemOnc doi.org/10.1158/1078-0…

Thrilled to share our story demonstrating NLRP3 infammasome as an androgen receptor (AR)-regulated phagocytic checkpoint within tumor-associated macrophages (TAM), which drives TAM-mediated tumor clearance upon priming with AR blockade and NLRP3 agonism: biorxiv.org/content/10.110…

Akash Patnaik, MD, PhD, MMSc crushing it with PCF Science Challenge Award 🎉 #PCFRetreat23

Honored to present our translational research at The V Foundation for Cancer Research symposium. Thank you for the invtation and your support! UChicagoCancerCenter UChicago Medicine University of Chicago Hematology/Oncology UniversityofChicago UChicago Committee on Cancer Biology